LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in Renal Clear Cell Carcinoma

doi:10.21203/rs.3.rs-1834426/v1

Download PDF

Article

LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in Renal Clear Cell Carcinoma

https://doi.org/10.21203/rs.3.rs-1834426/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Renal clear cell carcinoma (RCCC) is the most common type of renal cell carcinoma, which is also difficult to diagnose and easy to metastasize. Currently, there is still a lack of effective clinical diagnostic indicators and treatment targets. This study aims to find effective diagnostic markers and therapeutic targets from the perspective of noncoding RNA. In this study, we found that the expression of Long noncoding RNA LINC00472 was significantly decreased in RCCC and showed a downward trend with the progression of cancer stage. Patients with low LINC00472 expression have poor prognosis. Inhibition of LINC00472 significantly increased cell proliferation and migration, while overexpression of LINC00472 obviously inhibited cell proliferation and enhanced intercellular adhesion. Transcriptome sequencing analysis demonstrated that LINC00472 was highly correlated with extracellular matrix and cell metastasis related pathways, and the consistent results were obtained by The Cancer Genome Atlas (TCGA) data analysis. Additionally, we discovered that the integrin family protein ITGB8 is a target gene of LINC00472. Mechanistically, we identified that LINC00472 interacts with histone acetyltransferase P300 to regulate the acetylation level of H3K27 at the ITGB8 transcription start site, which is the first time to elucidate its function in the regulation of histone modification. Our analysis results illustrated that LINC00472 can be used as a potential diagnosis marker of RCCC, and our mechanism researches provide a theoretical basis for the clinical development of new and effective treatment strategies.

LINC00472

proliferation and migration

extracellular matrix

ITGB8

H3K27ac

P300

Renal cell carcinoma (RCC) is the most common and fatal cancer in the urinary system. Among all RCC types, renal clear cell carcinoma (RCCC) accounts for about 80% and it is also the most aggressive renal tumor.^{(1, 2)} The etiology of RCCC is complex, the related factors include genetic factors (such as deletion or inactivation of VHL gene), obesity, hypertension or antihypertensive treatment.^{(3, 4)} At present, the main obstacle of RCCC treatment is the lack of diagnostic markers and effective specific therapeutic targets. Patients with RCCC often have developed to advanced stage when diagnosed, and most of them have metastasized.^{(5, 6)} Therefore, finding reliable diagnostic factors and effective therapeutic targets is important to improve the therapeutic effect of RCCC.

Long noncoding RNAs (lncRNAs), which are functionally defined as transcripts > 200 nt in length with no protein-coding potential, have been found to be involved in a variety of cellular functions. ^(7–9) The main modes of action of lncRNA include: participating in the regulation of histone modification to change the conformation of chromatin and regulate gene transcription,^{(10, 11)} acting as scaffolds to promote the binding of protein to protein (or DNA), or directly interact with proteins to affect their localization or activity,⁽¹²⁾ and playing as a "sponge", competitively bind to miRNAs and then regulate the expression of target genes.^(13–15) It is worth noting that lncRNAs play important roles in multiple cancers, and the functions have been summarized in six aspects: proliferation, growth suppression, motility, immortality, angiogenesis, viability.^(16–18) Significantly, compared with the genes encoding proteins, most lncRNAs are non-conservative and tissue-specific, which provide a better choice for finding new disease treatment targets.^(19–21)

In this study, we found that the expression of lncRNA LINC00472 was significantly reduced in RCCC, and the prognosis of patients with low expression LINC00472 was poor. Moreover, we verified LINC00472 biological functions and found that it can inhibit cell proliferation and migration. Transcriptome sequencing analysis and TCGA data analysis indicated that LINC00472 was highly correlated with extracellular matrix and cell metastasis related pathways. Mechanistically, our results demonstrated that LINC00472 can interact with acetyltransferase P300 to regulate the level of H3K27ac in cells. In conclusion, LINC00472 could be an effective marker for clinical diagnosis and a potential molecular therapeutic target of RCCC.

Construction of WGCNA co-expression module

We divided RCCC samples into cancer and normal group according to the notes of TCGA and the Principal Component Analysis (PCA) showed that the samples could be divided into two obvious clusters (Fig. 1A). Then, we analyzed differentially expressed genes in both groups and identified 6303 up-regulated and 3563 down-regulated genes (|Log₂ Fold Change| > 1, p-value < 0.001). The Log₂ of enrichment ratio and -Log₁₀ of adjusted p-value were visualized in the volcano plot (Fig. 1B). Based on fold change, we selected 20000 genes with the most obvious absolute value change among the differentially expressed genes and performed weighted gene co-expression network analysis (WGCNA) in cancer and normal samples. According to the average connectivity of the network, we selected the appropriate soft threshold (beta) in cancer samples and normal samples respectively (Figure S1A and C), and detected the node connection number of scale-free network under the selected soft threshold (Figure S1B and D). The fractional-step algorithm is used to construct modules and merged sub modules with dissimilarity less than 0.3 (Fig. 1C and S2A), and 11 co-expression networks were finally obtained in cancer and normal group respectively (Fig. 1D and S2B).

We analyzed WGCNA results of two groups and found that there were some overlapping genes in different types of data modules. In order to further excavate meaningful genes, we performed cross analysis on the two groups data. Excluding C_Mod1 and N_Mod1 that cannot be clustered, we found that N_Mod2 and several cancer modules (C_M5, C_M4, C_M11, C_M1, C_M1, C_M2, C_M3) intersect significantly, suggesting that the expression pattern of these overlapping genes in cancer may have changed (Fig. 1E). Next, we analyzed the correlation between these six cancer modules and patient clinical survival time. The correlation coefficient in each pattern represented the relation between gene module and the clinical traits, which decreased in size from red to blue. Most notably, we found that there was a significant correlation between the green module (C_Mod4) and the patient clinical prognosis survival time (Fig. 1F). Next, we analyzed the correlation between green module genes and patient survival (PFI time and OS time), and the results showed most genes in this module have a strong correlation with patient survival (Fig. 1G and H).

Renal clear cell carcinoma patients with low expression of LINC00472 have poor prognosis

After determining the module which most closely related to patient survival, we analyzed the expression of lncRNAs in this module, and finally obtained five lncRNAs (LINC00472, LINC00152, LINC00271, LINC01503, LINC01510) with significant differences in expression (Fig. 2A-E). Next, we analyzed the relationship between the expression of these lncRNAs and patient survival. As shown in Fig. 2F-J and S2A-E, LINC00472, LINC00152, LINC00271 and LINC01510 had a strong relationship with the survival time of patients. LINC00271 is highly expressed in testis and has a relative low expression in kidney, while LINC00472 and LINC01510 are highly expressed in renal tissue. Previous studies have shown that LINC01510 and LINC00152 play important roles in RCCC, which indicating that our bioinformatics analysis is reliable and effective. But it is still not clear what function LINC00472 plays in RCCC, so we next carried out the study on the function and mechanism of LINC00472. We selected a group of samples from RCCC and adjacent tissues in GEO database (GSE40435), and analyzed the expression of LINC00472. The results also showed that LINC00472 decreased significantly in cancer tissues comparing with the adjacent tissues (Fig. 2K). In addition, we found that the level of LINC00472 decreased gradually with the progress of cancer stage (Fig. 2L). According to the results of bioinformatics analysis, we speculated that the deletion of LINC00472 may promote the development of RCCC.

Knockdown of LINC00472 expression increased cell proliferation and migration

We transfected HK-2, 769-P and Caki-1 cells with LINC00472 lentivirus interference plasmid and control plasmid respectively, and using RT-qPCR to detect the mRNA expression of LINC00472. The results showed that the expression of LINC00472 in cells transfected with lentivirus interference plasmid was significantly decreased (Fig. 3A-C). After puromycin screening, we obtained the HK-2 shLINC00472, 769-P shLINC00472 and Caki-1 shLINC00472 cell lines with LINC00472 stable low expression, as well as their corresponding control cell lines.

Subsequently, we detected the growth status of LINC00472 stable low expression cell line and control cell line by using cell counting kit-8 (CCK-8) and cell count. The CCK-8 results indicated that inhibition of LINC00472 significantly increased the cell proliferation (Fig. 3D-F). The results of cell count were consistent with CCK-8 (Fig. 3G and H). Moreover, we checked the level of proteins related to cell proliferation by using western blot, and the results showed that the levels of p21 protein which inhibited cell proliferation significantly decreased in 769-P shLINC00472 cell line comparing with control cell line, while the level of Cyclin D1 protein that promoted cell proliferation was significantly increased (Fig. 3I). Single cell clone formation experiment showed that inhibition of LINC00472 obviously enhanced the ability of cell clone formation of HK-2 and 769-P cell (Fig. 3J and K). Furthermore, Wound healing experiment and Transwell experiment demonstrated that knockdown of LINC00472 significantly increased cell migration in Caki-1 cell (Fig. 3L and M) and 769-P cell (Figure S4A and B). According to the above experimental results, we can determine that inhibition of LINC00472 promotes the cell proliferation and migration in RCCC cell.

Construction of LINC00472 knockdown and overexpression stable cell line by CRISPR-Cas9

Next, we constructed cell lines with stable knockdown and overexpression of LINC00472 by using CRISPR-Cas9. Different from the knockout of common coding protein genes, the frameshift mutation caused by unit point shearing has low effective for lncRNA knockdown.⁽²²⁾ And not only that, due to the long length of LINC00472, we could not completely remove it. Therefore, we decided to reduce LINC00472 expression level by removing the sequence of its transcription starting site (TSS) to affect its transcription. We designed two shear sites, one is in the promoter region before the TSS and the other is in the first exon after the TSS (Fig. 4A). After monoclonal screening and sequencing, we obtained the successfully sheared cell line HK-2 KO-PE and the control cell line HK-2 KO-NC. RT-qPCR results showed the expression of LINC00472 in HK-2 KO-PE cells was indeed downregulated (Fig. 4B). To obtain the cell line with stable overexpression of LINC00472, we inserted a CMV enhancer sequence into the promoter region (Fig. 4C). Similarly, after monoclonal screening and sequencing, we obtained the cell line with successful sequence insertion cell line HK-2 KI-CMV and control cell line HK-2 KI-CTR, and the RT-qPCR results indicated that LINC00472 was successfully overexpressed in HK-2 KI-CMV cells (Fig. 4D). Inserting or deleting a certain sequence of a gene usually has a great risk of changing the expression of adjacent genes (Fig. 4E). In order to determine whether our scheme will affect the expression of genes near LINC00472, we checked the mRNA level of adjacent gene LINC01626 by using RT-qPCR, and the results showed that the mRNA level of LINC01626 did not change in both HK-2 KO-PE cell line and HK-2 KI-CMV cell line comparing with the control cell line (Fig. 4F and G).

Overexpression of LINC00472 inhibited cell proliferation and enhanced intercellular connectivity

By inserting a CMV sequence, we obtained a cell line with high expression of LINC00472, and then we found an obvious and interesting phenomenon that is the cell morphology of LINC00472 overexpressed cell line changed obviously compared with the control cell line, and the cells no longer grew in dispersion, but grew in clusters (Fig. 5A). In addition, the results of western blot detection of cell proliferation related proteins and single cell clone formation indicated that overexpression of LINC00472 significantly inhibited cell proliferation and reduced the ability of clone formation (Fig. 5B and C). Previous results showed that the cells change to grow in clusters after LINC00472 overexpression, so we speculated that LINC00472 enhanced intercellular connectivity. Therefore, we detected the expression and distribution of CDH1 (also named E-cadherin), which could be used as a marker of intercellular adhesion. Immunofluorescence results indicated that the expression of CDH1 in HK-2 KI-CMV cells significantly increased and the distribution of CDHI among cells was more aggregated comparing with the cells of control group; On the contrary, the expression of CDH1 decreased significantly in HK-2 KO-PE cells comparing with control group (Fig. 5D). Moreover, we also detected the mRNA and protein level of CDH1 using RT-qPCR and western blot, and the results demonstrated that the level of CDH1 in LINC00472 high expression cell line was significantly higher than that in the control group, while it was the opposite in LINC00472 low expression cell line (Fig. 5E-G). In addition, we used monolayer cell permeability test to further reflect the degree of intercellular connectivity. The detection of FITC-Dextran fluorescence intensity showed that the cell permeability of LINC00472 high expression group was significantly lower than that of the control group, while the cell permeability of LINC00472 low expression group was distinctly higher than control group (Fig. 5H and I). The above experimental demonstrated that overexpression of LINC00472 could inhibit cell proliferation and significantly increase the intercellular connection.

LINC00472 is highly correlated with extracellular matrix and cell metastasis related pathways

To further analyze the function of LINC00472 in cells, we performed RNA sequencing (RNA-seq) on two pairs of cell lines (HK-2 KI-CTR and HK-2 KI-CMV, HK2 KO-NC and HK-2 KO-PE) constructed by CRISPR-Cas9. RNA-seq results indicated that the main item obtained from GO enrichment analysis is extracellular matrix (Fig. 6A). Reactome enrichment analysis also showed that the changed pathways mainly focus on the extracellular matrix organization and cell membrane, involving matrix metalloproteinases (MMPs) family activation, integrin cell surface interactions and so on (Fig. 6B). Remarkably, most of the functions and pathways obtained by enrichment analysis are related to cell metastasis.

Next, we divided TCGA RCCC samples into high expression and low expression groups according to the median expression level of LINC00472, and then analyzed the expression levels of MMPs family members, integrin subunit family members and cadherin family members in the two groups of samples. As shown in Fig. 6C, the expression level of most members of MMPs family in LINC00472 low expression group was higher than that in LINC00472 high expression group. Proteins in MMPs family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in cancer processes, especially cell metastasis. According to the analysis results, we can infer that the low expression of LINC00472 enhances the decomposition of extracellular matrix by MMPs family, and then promotes cell metastasis. In addition, the analysis of cadherin family proteins and integrin subunit family proteins showed that the expression level of most members of the two family in LINC00472 high expression group was higher than that in LINC00472 low expression group (Fig. 6D and E). These analyses further demonstrated that the high expression of LINC00472 could enhance cell adhesion and connection, thus reducing the ability of cell metastasis.

Besides, we calculated the differential genes of high and low expression groups and analyzed their functional enrichment. GO and KEGG analysis showed that the differentially expressed genes were still mainly enriched in the regulation of extracellular matrix and cell adhesion (Figure S5A-C). These results are highly consistent with the analysis results of RNA-Seq. In addition, GSEA enrichment analysis showed that high expression of LINC00472 promoted the extracellular membrane-bounded organelle entries and inhibited the proliferation of epithelial cells, while low expression of LINC00472 reduced cell junction assembly and increased the regulation of cellular component movement (Fig. 6F-I). The above analysis results showed that the high expression of LINC00472 enhances the adhesion and connection between cells, which is consistent with the previous cell experiment results.

ITGB8 is a target gene regulated by LINC00472

We analyzed the RNA sequencing data of HK-2 KO-NC/KO-PE and HK-2 KI-NC/KI-CMV, and found 317 genes with the same expression level trend (Fig. 7A). Through PPI interaction analysis of the 317 genes in STRING database, we found a sub network located at the hub of the network, suggesting that these network node molecules may play an important role in the function of LINC00472 (Fig. 7B). Next, we detected the expression level of these network node molecules by using RT-qPCR, and the results showed that the expression of integrin family protein ITGB8 significantly decreased after LINC00472 was inhibited (Fig. 7C and D), and distinctly increased when LINC00472 was overexpressed (Fig. 7E). In addition, western blot and immunofluorescence results also displayed that the ITGB8 level was significantly up-regulated in LINC00472 high expression cell line and significantly decreased in LINC00472 low expression cell line (Fig. 7F-H). Therefore, we speculated that ITGB8 may be a potential target gene regulated by LINC00472. We analyzed the correlation between LINC00472 and ITGB8 in RCCC and normal tissues on GEPIA website. The results showed that the Spearman correlation coefficient between LINC00472 and ITGB8 was 0.4, indicating that there was a correlation between them (Fig. 7I). Furthermore, we also analyzed the relationship between the expression of ITGB8 and the prognosis of RCCC patients. As shown in Fig. 7J, the prognosis of patients with low expression of ITGB8 was significantly worse than that of patients with high expression of ITGB8, showing the same trend as LINC00472. So, how does LINC00472 regulate the expression of ITGB8?

LINC00472 interact with P300 to regulate histone modification

In the introduction section, we mentioned that lncRNA can regulate gene expression, and its main ways of action include participating in the regulation of histone modification and affecting the binding of miRNA to target genes. It is noteworthy that there are two obviously enriched histone modification peaks at the ITGB8 transcription start site (TSS) in the ChIP-Seq database that is H3K27ac and H3K4me3 (Fig. 8A, Figure S6A and C). Then, we designed six pairs of primers on upstream and downstream of ITGB8 TSS, and detected the levels of H3K27ac and H3K4me3 by using Chromatin Immunoprecipitation. The results showed that inhibition of LINC00472 significantly reduced the level of H3K27ac near the ITGB8 TSS (Fig. 8E and Figure S6D), while the level of H3K4me3 did not change (Fig. 8C and Figure S5B). Conversely, overexpression of LINC00472 obviously increased the level of H3K27ac near the ITGB8 TSS, while H3K4me3 not (Fig. 8D and F). The above results demonstrated that LINC00472 can regulate the level of H3K27ac near the ITGB8 TSS. Therefore, we speculate that LINC00472 is involved in the regulation of histone acetylation modification.

Subsequently, we analyzed the distribution of LINC00472 by RNA fluorescence in situ hybridization (FISH) and found that it was distributed both in the nucleus and cytoplasm, which providing a spatial possibility to participate in the regulation of histone modification. We checked the total level of H3K27ac in HK-2 and 769-P cells using western blot and the results demonstrated that the level of H3K27ac in LINC00472 low expression cell lines (HK-2 shLINC00472 and 769-P shLINC00472) significantly reduced comparing with the control cell lines (HK-2 shNC and 769-P shNC); On the contrary, the level of H3K27ac in LINC00472 high expression cell line (HK-2 KI-CMV) obviously increased comparing with the control cell line (HK-2 KI-CTR) (Fig. 8J). These results indicated that the deletion or overexpression of LINC00472 changed the total level of H3K27ac in cells. RPISeq provides two different methods (random forest, RF; support vector machine, SVM) to evaluate the possibility of protein binding to RNA. Using the algorithm support provided by RPISeq (http://pridb.gdcb.iastate.edu/RPISeq/) and lncPro (http://bioinfo.bjmu.edu.cn/lncpro/) database, we analyzed the possibility of interaction between histone modification participants and LINC00472. The results showed that LINC00472 had the highest correlation with P300 (Fig. 8H), a protein functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation.⁽²³⁾ Notably, RNA immunoprecipitation results indeed demonstrated that there was an interaction between LINC00472 and P300 (Fig. 8I). By analyzing the sequence and structure of LINC00472 and P300, we predicted the possible interaction sites between them (Fig. 8K). In addition, the results of RNA FISH and immunofluorescence also displayed that there was indeed spatial co-localization between LINC00472 and P300 (Fig. 8L). According to the above results, we can conclude that LINC00472 regulates the acetylation modification level of histone through interacting with P300.

RCCC is difficult to diagnose in the early stage and easy to metastasize.⁽²⁴⁾ Finding effective clinical diagnostic markers and molecular therapeutic targets is crucial to improve the therapeutic effect of RCCC. Noncoding RNA has been a hot research field in recent years, especially its functions related to cancer, neurodegenerative diseases and immune related diseases.^(25–27) Benefit by the non-conservation of noncoding RNA, it is easier for researchers to find specific molecular targets corresponding to a certain disease.⁽²⁸⁾ Here, we found a lncRNA LINC00472, which decreased significantly in RCCC and showed a downward trend with the progress of cancer stage, also has a highly correlated with the prognosis of patients.

LINC00472 has been shown to promote apoptosis and inhibit cell proliferation by regulating miR-24-3p/DEDD in lung adenocarcinoma.^{(29, 30)} Similarly, LINC00472 was found to promote cell apoptosis and suppresses cell proliferation through elevating PDCD4 expression by sponging miR-196a in colorectal cancer.⁽³¹⁾ There were also studies have shown that ERa can increase the level of LINC00472 and then inhibit the phosphorylation of NF-kB in breast cancer.^{(32, 33)} In our study, we found that inhibition of LINC00472 promoted cell proliferation, while overexpression of LINC00472 inhibited cell proliferation in RCCC, which are consistent with previous studies. In addition, we found that overexpression of LINC00472 could significantly inhibit cell migration. RNA-seq and TCGA enrichment analysis showed that LINC00472 was mainly involved in extracellular matrix pathway, MMPs family and integrin family protein regulation, which provides new and reliable evidence for LINC00472 to inhibit cell migration.

For the molecular mechanism, most early studies confirmed an important function of LINC00472, that is it can act as "sponge" to competitively bind miRNA to regulate the expression of target genes.^{(13, 34, 35)} We considered this function has an important relationship with its own structure. Due to its long sequence, there must be many potential binding sites of miRNA.⁽³⁶⁾ Interestingly, we found a potential target gene of LINC00472 through transcriptome sequencing and STRING analysis. By studying the mechanism of how LINC00472 regulates ITGB8, we found that LINC00472 can interact with acetyltransferase P300 to regulate the acetylation level of histone H3K27 site, which is the first report that LINC00472 is involved in the regulation of histone modification.

Of course, there are still many sections for further improvement and proof in our research. For example, the efficiency of knockdown of LINC00472 using CRISPR-Cas9 method needs to be further improved. In addition, our RNA FISH and immunofluorescence results displayed that LINC00472 co-located with P300 in cells. However, there are still part of LINC00472 that did not co-locate with P300, especially in the cytoplasm. What roles this part of LINC00472 play and whether it will also act as a " sponge " to bind miRNA need to be verified by further experiments.

Taken together, our study found a lncRNA LINC00472, which is significantly decreased in RCCC, may become a potential molecular marker for clinical diagnosis and prognosis. Moreover, we revealed its cellular function in RCCC and identified its highly related functional pathway. Most importantly, we first found that LINC00472 is involved in the regulation of histone modification. These results will provide a theoretical and experimental basis for the design of RCCC new treatment strategies.

Weighted Gene Co-Expression Network Analysis

R package “WGCNA” was used to perform weighted gene co-expression network analysis (WGCNA) using The Cancer Genome Atlas (TCGA) RCCC expression matrix (FPKM). To build a scale-free network and calculate network topology matrix, a gene expression matrix was weighted by a soft threshold. We used a dimension reduction algorithm to visualize the network module composed of co-expressed genes in RCCC samples after clustering with a dynamic cut tree algorithm and merging similar modules. The survival data of patients in TCGA are used for module correlation analysis, and the correlation between corresponding module genes and survival was visualized.

Publicly Available mRNA Data and ChIP-Seq Data

Our study incorporated data from two publicly available datasets. TCGA RNA-Seq data (FPKM value) of samples from patients with RCCC (Illumina HiSeq 2000) were acquired from Genomic Data Commons (GDC) (http://portal.gdc.cancer.gov. accessed on 23 April 2021). GSE40435 reported the whole genome expression data of tumor and adjacent non tumor renal tissues of 101 pairs of RCCC patients.⁽³⁷⁾ We obtained the data from GEO (https://www.ncbi.nlm.nih.gov/geo. accessed on 16 April 2021), and then further analyzed the microarray data according to the expression of LINC00472. The ChIP-seq data used in this project comes from the new WashU Epigenome Browser (http://epigenomegateway.wustl.edu/browser). We analyzed all renal tissue data in roadmap data from GEO and visualized it using this website.

Biological Process and Pathway Enrichment Analysis

DEGs between high- and low-LINC00472 expression groups were identified by using R package “DESeq2”.⁽³⁸⁾ Different pathways and items were identified between the two expression groups using Gene Ontology (GO), the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome enrichment analysis. In addition, we used GSEA to calculate dynamical scores for different enrichment items of high- and low-expression groups.⁽³⁹⁾

Cell culture and Construction of stable cell lines

HK-2 cells and 769-P cells were purchased from National Collection of Authenticated Cell Cultures (Shanghai, China). HK-2 cells were grown in DMEM/F12 (1:1) Medium with 10% fetal bovine serum (Gibco, California, USA). 769-P cells were cultured in RPMI 1640 Medium with 10% fetal bovine serum. All medium were supplemented with 10 U/ml of penicillin-streptomycin and all cells were cultured in a 5% CO2 humidified incubator at 37°C. The control shRNA and Lentivirus-based LINC00472-targeting shRNA vectors were purchased from GENECHEM (Shanghai, China). The sequence of shLINC00472#1 is “GCAACAGAAGTATGTGCAA”, shLINC00472#2 is “GCCAGTATATACTGAACAT”. HK-2 cells and 769-P cells were transiently transfected with these vectors and screened by puromycin at a concentration of 2 mg/ml to generate stable monoclonal cell lines.

CCK-8 and Cell Counts

Cell counting kit-8 (TRANS, FC-101) was used to detect cell proliferation according to the manufacturer’s instructions. Cell numbers was calculated by using Cell counter Scepter sensors 60mm (Millipore, PHCC60050).

Real-time quantitative PCR analysis

Real-time quantitative PCR (RT-qPCR) analysis was performed as previously described.⁽⁴⁰⁾ Total RNA was isolated using AG RNAex Pro Reagent (AG21101) according to the manufacturer’s protocol. Real-time quantitative PCR was performed using the TransScript All-in-One First-Strand cDNA Synthesis SuperMix for qPCR (One-Step gDNA Removal) (TRANS, AT341-01) and the PerfectStart SYBR Green qPCR SuperMix (TRANS, AT601-01). All the level of mRNAs were measured and normalized to β-actin, and the primers used are listed in Supplemental Table S1.

Construction and transfection of CRISPR-Cas9 plasmid

The sgRNAs were designed from E-CRISPR (http://www.e-crisp.org/E-CRISP/), and the CRISPR-Cas9 plasmids and control vectors were synthesized in GenePharma (Shanghai, China). Plasmid transfection was performed with Lipofectamine 3000 reagent (Invitrogen, USA) according to the manufacturer’s instructions. After 24 hours of transfection, added 2 mg/ml puromycin and cultured for two days, then diluted the surviving cells and transferred to 96 well plate for single cell screening. PCR and sequencing were used to identify whether the cells were successfully constructed.

RNA sequencing

Total RNA was isolated using AG RNAex Pro Reagent (AG21101) according to the manufacturer’s protocol. The purification, quality inspection and PCR library construction of samples were completed by GENE DENOVO (Guangzhou, China). Differentially expressed genes were identified using the “DESeq2” package with standard settings. Genes with a p adjust < 0.05 were considered differentially expressed, which were used for GO and KEGG enrichment analysis.

Western Blotting

Western blotting was performed as previously described.⁽⁴¹⁾ The antibodies used for western blotting include P27 (CST, 3686T), P21 (CST, 2947T), CyclinD1 (CST, 2978S), E-cadherin (Proteintech, 60335-01), ITGB8 (Abcam, ab243023), H3K27ac (Abcam, ab4729) and β-actin (CST, 8480S).

Cell permeability assay

The cells were planted in the transwell chamber placed in the well plate. After the cells were full, removed culture medium, washed with PBS, then added new culture medium containing 5 mg/ml FITC-Dextran (10KD), incubated in dark for 30 minutes, then collected the lower layer solution. The fluorescence intensity was detected by using multifunctional microplate reader (Beckman) at the wavelength of Ex 485 nm /Em 535 nm.

Immunofluorescence microscopy and FISH

Immunofluorescence was performed as previously described.⁽⁴²⁾ The cells were seeded into a well plate covered with glass slides. At the treated time, the cells were fixed in 4% formaldehyde for 10 min at room temperature, washed two times in PBS, then permeabilizated with 0.5% Triton-X 100 for 10 min at 4°C, and blocked with 3% BSA for 45 min at room temperature, followed by incubation for 1 h at room temperature with indicated antibodies. Washed 5 min each time for 3 times, and then incubated for 45 min with Alexa Flour secondary antibody (diluted 1:250 in blocking buffer). For RNA FISH, cells were fixed in 4% formaldehyde for 10 min at room temperature, washed two times in PBS, then permeabilizated with 0.5% Triton-X 100 for 10 min at 4°C, followed by incubation overnight at 37°C with LINC00472 specific probe (GenePherma, China). Cell images were obtained with confocal microscope (Olympus FV1000).

RNA immunocoprecipitation

RNA immunocoprecipitation was performed as previously described.^{(43, 44)} Briefly, cells were harvested and lysed with polysome lysis buffer (5 mM MgCl2, 10 mM KCl, 10 mM HEPES pH 7.0, 1 mM DTT, 0.5% NP-40, 100 U/ml RNase inhibitor, 20 µl/ml protein inhibitor calculator). Then lysed cells were incubated with 5 µg EZH2 (Abcam, ab191250) or P300 (Abcam, ab14984) antibody overnight at 4°C. Next, using polysome lysis buffer to wash the non-specifically binding antibodies and incubated with Dynabeads protein G (Invitrogen, USA) for 4–6 h at 4°C. Then washed and precipitated the RNA with ethanol and sodium acetate. The RNA fragments were reverse transcribed and analyzed by RT-qPCR.

Chromatin immunoprecipitation (ChIP)

ChIP assay was detected by using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) according to the manufacturer’s instructions (CST, 9003S). The ChIP grade antibodies include H3K4me3 (Abcam, ab8580), H3K27ac (Abcam, ab4729) and the IgG negative control of SimpleChIP® Enzymatic Chromatin IP Kit. The primers used for RT-qPCR analysis are listed in Supplemental Table S2.

Statistical analysis

Statistical analysis was performed using GraphPad Prism 8.0 version. Student’s t-test was used to make a statistical comparison between groups. P < 0.05 was considered statistically significant. Results were representative of at least three experiments under identical conditions.

Conflict of interests

The authors declare no conflict of interest.

Author Contributions

Songmao Wang and Cheng Luo designed the project and wrote the paper. Bing Li, Shikuan Zhang, Weijie Liao, Qilei Xin, Naihan Xu, Weidong Xie and Yuanchang Zhu finished experiments. Songmao Wang and Cheng Luo prepared all figures. All authors analyzed the results and approved the final version of the manuscript.

Funding

This study was supported by grants from the Shenzhen International Cooperation Research Project (GJHZ20180929162002061); National Natural Science Foundation of China (82060281).

Data Availability statement

The data sets generated and collected during this study will be available from the corresponding author upon reasonable request.

Yin L, Li W, Xu A, Shi H, Wang K, Yang H, et al. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine. 2020;51:102596.
Lu J, Zhu L, Zheng LP, Cui Q, Zhu HH, Zhao H, et al. Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965. EBioMedicine. 2018;34:85-93.
Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2020;180(1):207.
Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Renal cell carcinoma therapy: Current and new drug candidates. Drug Discov Today. 2021.
Chen B, Jiao Z, Yin X, Qian Z, Gu J, Sun H. Novel insights into biomarkers associated with renal cell carcinoma. Oncol Lett. 2018;16(1):83-90.
Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, et al. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell. 2016;29(1):104-16.
Wu H, Yang L, Chen LL. The Diversity of Long Noncoding RNAs and Their Generation. Trends Genet. 2017;33(8):540-52.
Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018;172(3):393-407.
Sun Q, Hao Q, Prasanth KV. Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. Trends Genet. 2018;34(2):142-57.
Sun X, Haider Ali MSS, Moran M. The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions. Biochem J. 2017;474(17):2925-35.
Zhu Y, You J, Wei W, Gu JJ, Xu C, Gu X. Downregulated lncRNA RCPCD promotes differentiation of embryonic stem cells into cardiac pacemaker-like cells by suppressing HCN4 promoter methylation. Cell Death Dis. 2021;12(7).
Xu Y, Wu W, Han Q, Wang Y, Li C, Zhang P, et al. New Insights into the Interplay between Non-Coding RNAs and RNA-Binding Protein HnRNPK in Regulating Cellular Functions. Cells. 2019;8(1).
<(2020-Eur Rev Med Pharmacol Sci)LINC00472 promotes osteogenic differentiation and alleviates osteoporosis by sponging miR-300 to upregulate the expression of FGFR2.pdf>. 2020.
Wang L-y, Shen H, Yang Q, Min J, Wang Q, Xi W, et al. LncRNA-LINC00472 contributes to the pathogenesis of atrial fibrillation (Af) by reducing expression of JP2 and RyR2 via miR-24. Biomedicine & Pharmacotherapy. 2019;120.
Guo K, Qian K, Shi Y, Sun TQ, Wang ZY. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. Cell Death Dis. 2021;12(12).
Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L. LINC00152: A pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017;50(4).
Yang ZZ, Li XJ, Yang YH, He ZW, Qu X, Zhang Y. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis. 2016;7.
Zhang SG, Liang SH, Wu DH, Guo HR, Ma K, Liu LX. LncRNA coordinates Hippo and mTORC1 pathway activation in cancer. Cell Death Dis. 2021;12(9).
Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R, Mendell JT. Noncoding RNAs and cancer. Cell. 2013;153(1):9-10.
Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29(4):452-63.
Shi Y, Wang Q, Song R, Kong Y, Zhang Z. Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers. EBioMedicine. 2021;71:103569.
Han J, Zhang J, Chen L, Shen B, Zhou J, Hu B, et al. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 2014;11(7):829-35.
Klempnauer KH. C/EBPbeta sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module. Exp Hematol. 2022.
Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018;23(12):3698.
Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J, et al. Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. Mol Cancer. 2020;19(1):64.
Hu Q, Egranov SD, Lin C, Yang L. Long noncoding RNA loss in immune suppression in cancer. Pharmacol Ther. 2020;213:107591.
Ye M, Zhang J, Wei M, Liu B, Dong K. Emerging role of long noncoding RNA-encoded micropeptides in cancer. Cancer Cell Int. 2020;20:506.
Wu M, Zhang X, Han X, Pandey V, Lobie PE, Zhu T. The potential of long noncoding RNAs for precision medicine in human cancer. Cancer Lett. 2021;501:12-9.
Su C, Shi K, Cheng X, Han Y, Li Y, Yu D, et al. Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/ DEDD. Technol Cancer Res Treat. 2018;17:1533033818790490.
Zhu TG, Xiao X, Wei Q, Yue M, Zhang LX. Revealing potential long non-coding RNA biomarkers in lung adenocarcinoma using long non-coding RNA-mediated competitive endogenous RNA network. Braz J Med Biol Res. 2017;50(9):e6297.
Chen L, Zhang W, Li DY, Wang X, Tao Y, Zhang Y, et al. Regulatory network analysis of LINC00472, a long noncoding RNA downregulated by DNA hypermethylation in colorectal cancer. Clin Genet. 2018;93(6):1189-98.
Wang Z, Katsaros D, Biglia N, Shen Y, Loo L, Yu X, et al. ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer. Breast Cancer Research and Treatment. 2019;175(2):353-68.
Shen Y, Wang Z, Loo LW, Ni Y, Jia W, Fei P, et al. LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. Breast Cancer Res Treat. 2015;154(3):473-82.
Chen C, Zheng Q, Kang W, Yu C. Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway. Clin Res Hepatol Gastroenterol. 2019;43(4):436-45.
Mao X, Zhou X, Liu J, Mao Y, Zhou H. Up-regulated Linc00472 suppresses development of lung cancer cell via inhibition of MiR-196b-5p. Bioscience, Biotechnology, and Biochemistry. 2019:1-13.
Chen Y, Pan Y, Ji Y, Sheng L, Du X. Network analysis of differentially expressed smoking‑associated mRNAs, lncRNAs and miRNAs reveals key regulators in smoking‑associated lung cancer. Experimental and Therapeutic Medicine. 2018.
Wozniak MB, Le Calvez-Kelm F, Abedi-Ardekani B, Byrnes G, Durand G, Carreira C, et al. Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States. PLoS One. 2013;8(3):e57886.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-50.
Wang S, Zou Z, Luo X, Mi Y, Chang H, Xing D. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer. Oncogene. 2018;37(24):3243-59.
Wang Z, Liu Q, Lu J, Fan P, Xie W, Qiu W, et al. Serine/Arginine-rich Splicing Factor 2 Modulates Herpes Simplex Virus Type 1 Replication via Regulating Viral Gene Transcriptional Activity and Pre-mRNA Splicing. J Biol Chem. 2016;291(51):26377-87.
Wang Z, Zhao Y, Xu N, Zhang S, Wang S, Mao Y, et al. NEAT1 regulates neuroglial cell mediating Abeta clearance via the epigenetic regulation of endocytosis-related genes expression. Cell Mol Life Sci. 2019;76(15):3005-18.
Liao M, Liao W, Xu N, Li B, Liu F, Zhang S, et al. LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine. 2019;41:200-13.
Zhu Y, Liu Q, Liao M, Diao L, Wu T, Liao W, et al. Overexpression of lncRNA EPB41L4A-AS1 Induces Metabolic Reprogramming in Trophoblast Cells and Placenta Tissue of Miscarriage. Mol Ther Nucleic Acids. 2019;18:518-32.

(Not answered)

Download PDF

Unknown event
04 Aug, 2022
Editorial decision: Reject after peer review
04 Aug, 2022
Review #2 received at journal
02 Aug, 2022
Review #1 received at journal
24 Jul, 2022
Reviewer #2 agreed at journal
23 Jul, 2022
Reviewer #1 agreed at journal
21 Jul, 2022
Reviewers invited by journal
21 Jul, 2022
Submission checks completed at journal
07 Jul, 2022
First submitted to journal
07 Jul, 2022
Editor assigned by journal
07 Jul, 2022

You are reading this latest preprint version

LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in Renal Clear Cell Carcinoma

Status:

Version 1

Abstract

Figures

Introduction

Results

Construction of WGCNA co-expression module

Renal clear cell carcinoma patients with low expression of LINC00472 have poor prognosis

Knockdown of LINC00472 expression increased cell proliferation and migration

Construction of LINC00472 knockdown and overexpression stable cell line by CRISPR-Cas9

Overexpression of LINC00472 inhibited cell proliferation and enhanced intercellular connectivity

LINC00472 is highly correlated with extracellular matrix and cell metastasis related pathways

ITGB8 is a target gene regulated by LINC00472

LINC00472 interact with P300 to regulate histone modification

Discussion

Materials And Methods

Weighted Gene Co-Expression Network Analysis

Publicly Available mRNA Data and ChIP-Seq Data

Biological Process and Pathway Enrichment Analysis

Cell culture and Construction of stable cell lines

CCK-8 and Cell Counts

Real-time quantitative PCR analysis

Construction and transfection of CRISPR-Cas9 plasmid

RNA sequencing

Western Blotting

Cell permeability assay

Immunofluorescence microscopy and FISH

RNA immunocoprecipitation

Chromatin immunoprecipitation (ChIP)

Statistical analysis

Declarations

References

Additional Declarations

Supplementary Files

Status:

Version 1